Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Viability of a drug-resistant human immunodeficiency virus type 1 protease variant: structural insights for better antiviral therapy.
Dynamic flux balance modeling of microbial co-cultures for efficient batch fermentation of glucose and xylose mixtures.
Disruption of human TRIM5alpha antiviral activity by nonhuman primate orthologues.
[Myocardial hypoperfusion due to microvascular dysfunction in hypertrophic cardiomyopathy: role of positron emission tomography].
Individual and composite study endpoints: separating the wheat from the chaff.
See All 9 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Individual and composite study endpoints: separating the wheat from the chaff.
Goldberg R, Gore JM, Barton B, Gurwitz J. Individual and composite study endpoints: separating the wheat from the chaff. Am J Med. 2014 May; 127(5):379-84.
View in:
PubMed
subject areas
Clinical Trials as Topic
Cost-Benefit Analysis
Endpoint Determination
Humans
Prospective Studies
Research Design
Sample Size
Treatment Outcome
authors with profiles
Robert Joel Goldberg PhD
Bruce A Barton PhD
Joel M Gore MD
Jerry Howard Gurwitz MD